Torsade de pointes induced by citalopram and amiodarone

Annales de Cardiologie et d'Angeiologie

Volumn 60, Issue 3, 2011, Pages 165-168

  Fayssoil, A ^a   Issi, J ^a   Guerbaa, M ^a   Raynaud, J C ^a   Heroguelle, V ^a  

^a Manchester hospital   (France)

Author keywords

Amiodarone; Citalopram; LQTS; TdP

Indexed keywords

AMIODARONE; CITALOPRAM; FLUINDIONE; LERCANIDIPINE; LOSARTAN; MAGNESIUM SULFATE; POTASSIUM;

AGED; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DEPRESSION; DIZZINESS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART PALPITATION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; HYPOKALEMIA; QT PROLONGATION; SYSTOLIC HEART MURMUR; TORSADE DES POINTES; TREATMENT OUTCOME;

AGED, 80 AND OVER; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CITALOPRAM; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONG QT SYNDROME; SEROTONIN UPTAKE INHIBITORS; TORSADES DE POINTES;

EID: 79959266266     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2010.12.002     Document Type: Article

References (9)

1. Dessertenne F. Ventricular tachycardia with 2 variable opposing foci. Arch Mal Coeur Vaiss 1966, 59:263-272.
2. Tarabar A.F., Hoffman R.S., Nelson L. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest. J Med Toxicol 2008, 4(2):101-105.
3. Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation 2009;119(10):e241-50.
4. Al-Khatib S.M., LaPointe N.M., Kramer J.M., Califf R.M. What clinicians should know about the QT interval. JAMA 2003, 289:2120-2217.
5. Kanjanauthai S, Kanluen T, Chareonthaitawee P. Citalopram induced torsade de pointes, a rare life threatening side effect. Int J Cardiol 2008;131(1):e33-4.
6. Hohnloser S.H., Klingenheben T., Singh B.N. Amiodarone-associated proarrhythmic effects. A review with special reference to Torsade de pointes tachycardia. Ann Intern Med 1994, 121:529-535.
7. Hii J.T., Wyse D.G., Gillis A.M., Duff H.J., Solylo M.A., Mitchell L.B. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992, 86:1376-1382.
8. Lim H.E., Pak H.N., Ahn J.C., Song W.H., Kim Y.H. Torsade de pointes induced by short-term oral amiodarone therapy. Europace 2006, 12:1051-1053.
9. Monraba R., Sala C. Percutaneous overdrive pacing in the out-of hospital treatment of torsades de pointes. Ann Emerg Med 1999, 33:356-357.